The partnership marks the next phase of xStocks, expanding the tokenised equities framework beyond U.S. stocks and ETFs to include equities from international markets and, over time, other asset classes. Subject to the required licences, it also plans to bring tokenised assets to GTN’s institutional network

DUBAI, UAE and ST. HELIER, Jersey, July 23, 2026 /PRNewswire/ — GTN, the fintech powering limitless investment, and Payward, the developer of the xStocks tokenised equities framework and parent company of Kraken, have partnered to enhance and accelerate the global expansion of the xStocks offering.

The partnership unlocks a pathway for xStocks to significantly scale the range of equities it tokenises, beginning by tokenising equities listed in Hong Kong, before expanding to tokenise UK-listed assets, European assets, South Korean assets, and more, delivering an unrivalled breadth of international market access that no other tokenised framework offers today. It also opens the opportunity to expand xStocks beyond tokenised equities for the first time, broadening the framework to new tokenised asset classes. For individual holders, it means tokenised assets from markets across the world and multiple asset classes can sit side-by-side in one portfolio, held onchain, tradeable 24/7, and portable across the 100+ exchanges, wallets, and DeFi applications where xStocks already trade.

GTN provides the global execution and custody for the traditional assets underlying xStocks’ expansion. Spanning a broad range of asset classes across 90+ markets through a single integration, GTN is the partner making the next phase of xStocks possible, providing a route to scale its tokenised offering beyond U.S. equities to equities listed in international markets and, over time, new asset classes, each subject to regulatory approvals. Tokenisation’s promise has always been to make the world’s markets accessible to more people from a single place, and this partnership is a key step toward that goal.

Under the agreement, GTN provides infrastructure to support the ledgering and record-keeping of tokenised products, helping token issuers account for the underlying assets. Subject to GTN obtaining the required licences in each market, GTN would also make a range of xStocks available to its institutional clients alongside its existing offering. Because GTN reaches a range of asset classes across 90+ markets, the partnership also creates pathways for the xStocks ecosystem to diversify the assets it lists to the hundreds of centralised exchanges, self-custody wallets, and DeFi protocols where it already trades.

“For decades, we’ve accepted that capital markets should be fragmented by country, currency, and market hours,” said Mark Greenberg, Global Head of Payward Services. “That’s a legacy financial infrastructure problem. The biggest asset class that hasn’t been tokenized yet is the rest of the world, and our partnership with GTN is about changing that. One asset at a time, we’re bringing truly global capital markets onchain until geography becomes irrelevant to investing.”

“Financial institutions want to move into new asset classes and markets without rebuilding their technology. Our infrastructure lets partners like Payward launch quickly across 90+ markets and a full range of instruments, and it includes the sub-accounting technology Kraken needs to offer tokenised products. We are delighted that Payward has selected GTN as a global product expansion partner,” said Ankit Shah, Global Head of FinTech, GTN.

xStocks launched a year ago with tokenised U.S. stocks and ETFs, backed 1:1 by the underlying assets. It has since grown and broadened to more than 500 tokenised assets spanning equities, ETFs, and IPOs, the widest range offered by any tokenised equities framework, and now power over $35 billion dollars in transaction volume across multiple blockchain ecosystems, and has amassed nearly 200,000 holders across the world. The GTN partnership marks the start of its next phase, extending that framework beyond U.S. capital markets for investors around the world.

The partnership is already live, with tokenised distribution to GTN’s institutional clients to follow once the required licences are in place. By combining GTN’s regulated infrastructure with Payward’s platform, the two companies aim to make a wider range of assets and markets accessible to institutions worldwide, and will share details on enhanced offerings in the coming weeks.

About Payward 
Payward, Inc. is a unified financial infrastructure platform that powers a family of products advancing an open, global financial system. Built on a single shared architecture, Payward enables customers to hold, trade, earn, pay, and invest across asset classes without friction or fragmentation.

At its core, Payward provides the infrastructure layer behind Kraken and a growing set of purpose-built products, including NinjaTrader, Breakout, xStocks, and CF Benchmarks.

Payward separates infrastructure from product expression. Each product surface is designed for a specific customer segment, regulatory regime, and use case, while operating on the same global foundation:

• One global liquidity pool
• One unified risk and margin engine
• One collateral and settlement system
• One compliance and licensing framework

This shared architecture allows Payward to scale efficiently, launch new products at low marginal cost, and serve diverse global markets while maintaining consistent risk management, regulatory integrity, and operational resilience.

For more information about Payward, please visit www.payward.com.

About xStocks
xStocks is the industry benchmark for tokenized equities, bringing publicly listed U.S. stocks and ETFs onchain through fully collateralized, 1:1-backed tokens. Powered by Payward’s digital asset infrastructure, xStocks provides exposure to traditional equities on blockchain infrastructure, expanding access to U.S. capital markets with extended availability, global reach, and seamless digital-native settlement.

Designed for interoperability, xStocks move seamlessly between centralized exchanges, self-custodied wallets, and onchain applications, unlocking new utility across trading, collateralization, and decentralized finance. Since launching in June 2025, xStocks is powering billions of dollars in transaction volume across multiple blockchain ecosystems and anchors a rapidly expanding global network shaping the future of tokenized markets. For more information, visit https://xstocks.fi.

About GTN
GTN is the global fintech infrastructure powering limitless investment through a unified API-first architecture. By combining cloud-native technology with deep institutional expertise, GTN provides brokers, banks, asset managers, and fintechs with brokerage infrastructure spanning 90+ markets and 8 asset classes through a single API, enabling partners to create the next generation of investing and trading experiences. From fractional trading and micro-portfolios, including $1 fractional bonds, to full-service brokerage, GTN automates the investment lifecycle from digital onboarding to post-trade settlement. As a single counterparty, GTN reduces technical and regulatory burdens, enabling investment banks, brokerage firms, and wealth management firms to scale without having to build technology from scratch.

With over 600 professionals across 14 countries, and serving 500+ clients globally, we’re united by one mission: transforming the accessibility of investment and trading opportunities for all. Regulated across six jurisdictions (FCA, DFSA, MAS, FINRA, FSCA, SFC), GTN is backed by strategic investors including IFC (World Bank Group) and SBI Ventures Singapore. Learn more at www.gtngroup.com or follow us on LinkedIn.

Important information
This announcement is for informational purposes only. It is not investment, legal or tax advice, and it is not an offer or solicitation to buy or sell any security, token or other financial instrument. xStocks are issued by Backed Assets (JE) Limited (a Jersey private limited company) and offered to eligible Kraken customers via Payward Digital Solutions Ltd. (“PDSL”), a company licensed to conduct digital asset business by the Bermuda Monetary Authority, and to eligible EU customers via Payward Europe Digital Solutions Ltd., a company authorised and regulated by the Cyprus Securities and Exchange Commission. xStocks are not offered or available in the United States or to U.S. persons, and other geographic restrictions apply. xStocks are not, nor will they be registered with any local securities regulators. The availability of products and services varies by jurisdiction and is subject to local regulatory requirements and approvals. GTN’s provision of any services described is subject to GTN obtaining the relevant regulatory licences in each market. Tokenised and cryptoasset products carry significant risk, including the risk of total loss, may be unregulated, and may not be covered by statutory compensation schemes; the value of investments can go down as well as up. Read Kraken’s xStocks Risk Disclosure at kraken.com/legal/xstocks as well as the Base Prospectus and related Final Terms for xStocks at https://assets.backed.fi/legal-documentation to learn more.

This announcement contains forward-looking statements that reflect current expectations and are subject to change, including as a result of regulatory, market and technological developments. GTN and Payward undertake no obligation to update them.

• Recorded Q2’26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion
• Delivered stable business performance through continued disciplined execution
• Expanded global presence while advancing innovation and future growth initiatives

INCHEON, South Korea, July 23, 2026 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), reported financial results for the second quarter of fiscal year 2026.

“We delivered another quarter of solid execution while making meaningful progress on our growth strategy,” said John Rim, President and CEO of Samsung Biologics. “Our continued investments in global operations and future capabilities are strengthening the foundation of our business and preparing us for the next phase of industry growth. As the biopharmaceutical landscape evolves, we remain committed to providing the scale, flexibility, and expertise our clients need to bring next-generation therapies to patients.”

Financial Highlights

Samsung Biologics reported revenue of KRW 1,321 billion and operating profit of KRW 586 billion for the second quarter of 2026. Performance during the quarter reflected stable manufacturing operations across Plants 1 through 4 and disciplined execution across ongoing client programs. The company posted revenue of KRW 2,578 billion and operating profit of KRW 1,167 billion for the first half of 2026.

Cumulative contract value reached USD 21.6 billion, reflecting sustained demand from global clients for the company’s integrated development and manufacturing services.

[Consolidated earnings for CDMO business, KRW billion]

Business Updates and 2026 Outlook

Alongside stable business performance, Samsung Biologics made further progress on initiatives supporting its long-term growth strategy.

Following the acquisition of its Rockville manufacturing facility in Maryland, U.S. earlier this year, the company continued to integrate the site into its global manufacturing network while maintaining ongoing commercial manufacturing operations. Plant 5 remained on track for its planned ramp-up, with Process Performance Qualification (PPQ) activities gaining momentum during the quarter. Together, these milestones further expand Samsung Biologics’ manufacturing network and reinforce its readiness to support future client programs.

Samsung Biologics also broadened its global presence through the opening of its Netherlands sales office in the third quarter of 2026, enhancing client proximity while strengthening regional support across Europe.

The company continued efforts to foster innovation across the biopharmaceutical ecosystem through the Life Science Fund, created jointly by Samsung Biologics, Samsung Bioepis, and Samsung C&T, and managed by Samsung Venture Investment. In May, the fund invested in Cartography Biosciences to support global collaboration in genomics-based antigen discovery and oncology drug development, and the following month, an additional investment worth KRW 200 billion was made to create the third Life Science Fund.

Samsung Biologics also plans to further advance its proprietary platform technologies to strengthen its core CDMO capabilities and expand expertise across diverse modalities, supporting changing industry needs and future innovation.

On the sustainability front, Samsung Biologics was included in the Dow Jones Best-in-Class Indices for the fifth consecutive year, a recognition of the company’s ongoing commitment to responsible business practices. During the quarter, the company also published its annual ESG report, further strengthening transparency and stakeholder engagement.

Samsung Biologics remains on track to achieve the upper end of its previously announced 2026 guidance. Looking ahead, the company will continue executing its expansion strategy through ongoing investments in its manufacturing network, global operations and future capabilities. The recently announced all-cash public tender offer to acquire PolyPeptide Group, which is expected to be completed toward the end of 2026, represents another strategic step toward broadening the company’s portfolio into peptide therapeutics, expanding its global network, and reinforcing operational resilience in the face of evolving market demand.

For more details on performance and financials, please refer to the Earnings Release.

About Samsung Biologics Co., Ltd.

Samsung Biologics (KRX: 207940.KS) is a leading contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial manufacturing.

With a combined biomanufacturing capacity of 785,000 liters across Bio Campus I and II in Korea, and 60,000 from the acquisition of a manufacturing facility in Rockville, Maryland, U.S., Samsung Biologics holds total global manufacturing capacity of 845,000 liters. Samsung Biologics has also secured land for Bio Campus III, laying the groundwork for future capacity expansion to support next-generation therapies and emerging modalities.

Samsung Biologics leverages cutting-edge technologies and expertise to advance diverse modalities, including multispecific antibodies, fusion proteins, antibody-drug conjugates, and mRNA therapeutics.

By implementing the ExellenS™ framework across its manufacturing network with standardized designs, unified processes, and advanced digitalization, Samsung Biologics ensures plant equivalency and speed for manufacturing continuity.

Samsung Biologics’ global manufacturing and commercial network spans Korea, the U.S., and Japan. Samsung Biologics America supports clients based in the U.S. and Europe, while its Tokyo sales office serves the APAC region. Samsung Biologics continues to invest in new capabilities to maximize operational and quality excellence, ensuring flexibility and agility for clients. Samsung Biologics is committed to the on-time, in-full delivery of safe, high-quality biomedicines, as well as to making sustainable business decisions for the betterment of society and global health.

For more information, visit https://samsungbiologics.com/.

Media contacts

Claire Kim, Senior Director cair.kim@samsung.com
Becky Lee, Director brite.lee@samsung.com

Book by August 31 to enjoy early bird fares on Sydney–Seoul flights

SYDNEY, July 23, 2026 /PRNewswire/ — T’way Air has partnered with the Korea Tourism Organization (KTO) to offer early bird fares on its Sydney–Seoul (Incheon) route. With bookings now open for the airline’s Winter 2026 schedule, travelers can secure discounted fares for trips to Korea through March 27, 2027.

T’way Air currently operates three weekly flights between Sydney and Seoul using the Airbus A330-300. From October 2026, the airline will increase the service to daily flights, providing travelers with greater flexibility and convenience. During the Winter 2026 schedule (October 25, 2026–March 27, 2027), flights depart Sydney at 12:15 p.m. and arrive in Seoul at 9:15 p.m., while return flights depart Seoul at 9:40 p.m. and arrive in Sydney at 10:15 a.m. the following day.

The following offers are available for Sydney (SYD)–Seoul (ICN) bookings through August 31, with travel valid through March 27, 2027:

• Up to 8% off with promo code JUL26, applicable to both Economy and Business Class fares.
• AUD 30 Regular Coupon on bookings of AUD 500 or more, valid for travel between July 1, 2026 and March 27, 2027.
• AUD 50 Early Bird Coupon on bookings of AUD 600 or more, valid for travel between November 1, 2026 and March 27, 2027.

Whether planning a winter escape, a spring getaway, or a cultural adventure, Korea offers something to enjoy in every season—from Seoul’s vibrant shopping districts and diverse dining scene to its historic palaces and year-round festivals.

For full flight schedules, coupon terms, and booking details, visit twayair.com. T’way Air currently serves 60 destinations worldwide.

About T’way Air (Rebranding as Trinity Airways)

T’way Air Co., Ltd. is a South Korean low-cost carrier (LCC) operating since 2010, serving destinations across East Asia, Southeast Asia, Central Asia, Oceania, Europe and North America. Following shareholder approval and regulatory clearance from South Korea’s Ministry of Land, Infrastructure, and Transport, T’way Air is rebranding as Trinity Airways Co., Ltd. The new brand will enter service once all domestic and international approvals are secured, with the official launch date to be announced in due course. All existing bookings remain valid and no action is required from passengers. For more information, visit twayair.com.

Media Contact

T’WAY AIR Public Relations

twaypr@twayair.com

Former Dropbox, SAP, and Decagon go-to-market leader will bring Lorikeet’s AI concierge to more regulated teams resolving their hardest support cases.

SYDNEY, July 23, 2026 /PRNewswire/ — Lorikeet, the AI concierge platform for complex, regulated businesses, today announced that Jerry Brooner has joined as Chief Revenue Officer. Brooner will lead Lorikeet’s sales, marketing, forward-deployed engineering, and partnerships teams as the company expands across fintech, healthcare, and insurance.

Companies in high-stakes categories use Lorikeet to resolve complex cases end to end, accurately and within their regulatory guardrails. When a user asks why an account is frozen or whether a claim is covered, the answer has to be right the first time. Most AI support tools are measured on deflection; Lorikeet is measured on resolution.

“Our customers trust Lorikeet with the cases where a wrong answer has real consequences. Jerry has spent his career selling to buyers who are embracing the risk and reward of transformative technology, and he starts with a focus on their needs, not our pitch,” said Steve Hind, Lorikeet cofounder and CEO.

Brooner brings more than two decades of enterprise go-to-market leadership. He built Dropbox’s strategic enterprise business in North America from two people to over 250 and roughly $175 million in revenue, and led the Americas through its IPO. He was CRO of Scout RFP through its acquisition by Workday, President of Global Field Operations at Enable through 20x growth from Series A to Series E, and spent a decade at SAP selling to the world’s largest regulated enterprises.

“Lorikeet stood out because the product holds up in the hardest support environments, the regulated ones where the answer has to be right. My job is to bring it to many more of those teams, and I’m looking forward to building that here,” said Brooner.

About Lorikeet

Lorikeet is the AI concierge platform that resolves complex customer issues end to end within each company’s guardrails, for digital-native scale-ups in regulated industries like fintech, healthcare, and insurance. Co-founded by CEO Steve Hind (previously at Stripe) and Jamie Hall (one of the earliest LLM researchers at Google Brain), Lorikeet has teams in Sydney, the US, and the UK. Learn more at lorikeetcx.ai.

HONG KONG, July 22, 2026 /PRNewswire/ — On 22 July, the Southeast Asia-Hainan-Hong Kong (SEA-H2X) international submarine cable, led and invested in by China Mobile, completed the system acceptance test and launched commercially. As the project’s largest investor, China Mobile holds key management responsibilities and continues to play a driving role in its execution.

The SEA-H2X international submarine cable spans approximately 5,746 kilometers, featuring eight fiber pairs along the trunk and a system design capacity exceeding 200 Tbps. It connects Hainan, China, Hong Kong, China, the Philippines, Thailand, and Singapore. The project employs industry-leading open cable access technology (Open Cable) with spectrum sharing capabilities. It also incorporates advanced core submarine equipment to deliver ultra-high transmission capacity, while effectively enhancing operational security, service configuration agility, and reliability in complex networking environments.

China Mobile has invested in and constructed four trunk fiber pairs linking Hong Kong, China and Singapore, as well as branch segments to Hainan, China, the Philippines, and Thailand, securing over 100 Tbps of dedicated bandwidth upon commissioning. As the operator of the SEA-H2X Network Operations Center (NOC), China Mobile provides professional services including real-time monitoring, fault diagnosis, and performance optimization, comprehensively ensuring the safe and stable operation of the submarine cable system and improving user network experience.

In response to the rapidly growing demand for computing power interconnection in the AI era, SEA-H2X will further improve China Mobile’s communication infrastructure layout in Greater China and the Asia-Pacific region, helping to build a 30-millisecond-level low-latency computing power circle between China and Southeast Asia, and providing low-latency, end-to-end security, and cost-effective computing power scheduling capabilities. China Mobile will integrate SEA-H2X with its existing Asia-Pacific submarine cable systems, such as APG, SJC, and SJC2, as well as intercontinental cables including SEA-ME-WE 5, PEACE, IAX system, and its global terrestrial network, PoPs (Points of Presence), data centers, and intelligent computing resources, to establish a cross-continental transmission corridor spanning Asia-Pacific, the Middle East, and Europe. This enhances the resilience of the global communication network and provides a more reliable one-stop global connectivity service.

The commercial launch of the SEA-H2X cable marks a significant milestone in China Mobile’s efforts to advance high-quality digital infrastructure under the Belt and Road Initiative. By forging closer links between the Guangdong-Hong Kong-Macao Greater Bay Area, the Hainan Free Trade Port, and core Southeast Asian markets, the project provides a robust network foundation to support the overseas expansion of Chinese enterprises and drive digital development across the region. Looking ahead, China Mobile will leverage the deployment of SEA-H2X to deepen international digital cooperation, injecting new momentum into the growth of regional and global digital economies.

The new capability adds always-on research layer into AI workspaces where clients conduct critical analysis

NEW YORK, July 22, 2026 /PRNewswire/ — GLG, the world’s leading platform for trusted human expertise, today announced the launch of a Model Context Protocol (MCP) connector, giving clients continuous access to expert research within the AI tools they use daily. The connector enables users to directly call on insights from the world’s top experts and compare, modulate, and coalesce qualitative findings into any step of AI-enabled research workflows, all in accordance with GLG’s standard-setting compliance framework.

“We’re building the future of expert research based on an essential premise – that artificial intelligence can expand access to human intelligence, and unlock more of its true value,” said GLG CEO Gemma Postlethwaite. “As our clients continue to invest in AI to power their research and decision-making, GLG’s MCP capability represents a critical leap toward that future.”

The GLG MCP connector enables client users to query their complete project call history alongside original, named expert perspectives from GLG’s Expert Content Library directly within their AI platforms, an industry-leading capability. It’s also designed to incorporate an agent that can build nuanced research angles with conversational input, enabling users to seamlessly initiate primary research, surface new experts, and synthesize insights without leaving their internal AI tools. Throughout the workflow, users can trace every query output back to specific expert conversations or pieces of content.

“By enabling clients within the platforms and processes they’ve optimized for their work, the GLG MCP connector eliminates friction at every step of the research lifecycle, creating a smoother, faster path from question to insight to action,” said Chief Product Officer John Londono. “We’ve been encouraged by feedback from clients who helped us build and test the architecture, so we’re excited to release it globally and continue enhancing the expert research experience with further innovations.”

In line with GLG’s robust compliance framework, compliance officers will retain full control over what enters users’ AI tools.

New capabilities will be released on a rolling basis as GLG’s MCP connector becomes the integral, always-on expert research layer built into the agentic workflows where client organizations and teams operate.

About GLG
GLG is the world’s leading platform for trusted human expertise, connecting decision makers to the precise intelligence they need to gain a strategic edge. Leveraging decades of experience and proprietary data, GLG’s global teams recruit and engage hard-to-access experts across every industry – delivering fresh, authoritative insights, events, advisors, and board placements to the world’s most recognized and influential companies. Visit GLG.com. 

press@glg.it